Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | +34.78% | +93.75% | +181.82% |
06-26 | Actinogen Medical Limited Announces the Peer-Reviewed Publication of its Phase 2a Biomarker | CI |
06-26 | Actinogen Medical's Xanamem Drug 'Potentially Slows' Progression of Alzheimer's Disease | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ACW Stock
- News Actinogen Medical Limited
- Official Publications